Lv2
180 积分 2025-09-03 加入
Systemic immune-inflammation index (SII) may be an effective indicator in predicting the left ventricular hypertrophy for patients diagnosed with hypertension
4个月前
已完结
AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults
5个月前
已完结
Prevention and treatment of hypertensive left ventricular hypertrophy
5个月前
已完结
Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment
5个月前
已完结
A Multi-Center, Open-Label, Two-Arm Parallel Group Non-inferiority Randomized Controlled Trial Evaluating the Effect of Pitavastatin, Compared to Atorvastatin, on Glucose Metabolism in Prediabetics with Hypertension and Dyslipidemia: Rationale and Design for the China Hemoglobin A1c Metabolism Protection Union Study (CAMPUS)
5个月前
已完结
Epidemiology of left ventricular hypertrophy in hypertension: implications for the clinic
5个月前
已完结
Interactions of hypertension, obesity, left ventricular hypertrophy, and heart failure
5个月前
已完结
皖公网安备34019202002308
